AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 2381 businesses audited.
Unclear / Mixed / Unclassifiable Industry BS: TRODELVY (Gilead Sciences, Inc.) (trodelvy.com)
This site is the antithesis of bullshit. It functions as a clinical data repository where every marketing claim is legally and scientifically anchored to Phase 3 trial results. The only ‘points’ earned are for the lack of structured identity data (Schema) and the inherent repetition required by pharmaceutical regulations.
Implement Organization and Product JSON-LD schema to provide search engines with a verified link to Gilead Sciences and regulatory status. Replace the ‘Actor portrayal’ disclaimer on the ‘How it Works’ video with a dual-track approach that includes verifiable commentary from the actual clinical researchers. Ensure all clinical trial citations link directly to the peer-reviewed publications (e.g., NEJM or ASCO) rather than just internal summaries. Maintain the current ratio of data-to-text, as it is the primary driver of the low BS score.
The site exhibits extremely high substance-to-fluff ratios. Unlike typical corporate sites, the body text is packed with forensic data points such as median overall survival (14.4 months vs 11.2 months for HR+/HER2- mBC) and specific clinical trial participant counts (n=543 and n=529). Fluff-heavy power words are almost non-existent in headings, which prioritize descriptive clinical functions like [H3] Important Safety Information and [H2] TRODELVY targets cells with Trop-2.
AI crawlers don't scroll, click, or wait — they take whatever the raw HTML gives them. Start your free crawl layer inspection and see whether your site is actually reachable in an AI native environment.
There is zero detectable semantic drift between the homepage and sub-pages. The homepage establishes the two primary indications (mTNBC and HR+/HER2- mBC), and the sub-pages provide granular Phase 3 clinical data that directly supports those claims. The messaging remains clinical, transparent, and consistent across all examined slots.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The site avoids trust theatre entirely; there are no unverified five-star review widgets or generic ‘trusted by’ logos. Instead, it provides a 0 review_count but offsets this with high-authority proof paths to the FDA MedWatch program and specific Phase 3 clinical trial citations. Performance claims regarding survival are not presented as ‘results may vary’ fluff but as statistically significant median outcomes from controlled studies.
Proof density is exceptionally high, with 8+ instances of specific evidence (months of survival, trial sizes, molecular targets) found across all sub-pages. Every primary claim regarding drug efficacy is accompanied by a footnote or a dedicated results section detailing the Phase 3 trial parameters.
For a concrete demonstration of how the methodology exposes structural, semantic, and commercial gaps in a real hospitality brand, review a full executive level diagnostic applied to a coastal 4 star resort. View the Connemara Coast Hotel Executive SEO Strategy to see how positioning drift, UX friction, and experience SEO failures are surfaced in practice.
The fingerprint is minimal because the value proposition is tied to a specific chemical entity (sacituzumab govitecan-hziy) rather than generic service cliches. The only match to the patterns dictionary is the phrase ‘designed differently,’ but this is immediately qualified by a technical explanation of Antibody-Drug Conjugate (ADC) technology. No generic ‘Why Choose Us’ or ‘World Class’ templates are used.
The primary gap is technical rather than rhetorical, as the schema_json is null across all pages, missing an opportunity to link the brand to Gilead Sciences via Organization schema. While the site features a ‘Dr. Esposito,’ it transparently labels the content as ‘Actor portrayals,’ which prevents a penalty for deceptive authority but lacks a direct link to the real medical researchers behind the drug.
There is no disconnect between marketing tone and demonstrated evidence. The site claims the drug helps people live longer and immediately provides the delta in months (e.g., a 4.9-month improvement in median overall survival for mTNBC) to prove it. These are not ‘bold performance claims’ in a marketing sense but ‘verifiable clinical outcomes.’
Unclear / Mixed / Unclassifiable Industry BS: TRODELVY (Gilead Sciences, Inc.) (trodelvy.com)
The website is a textbook example of a regulated pharmaceutical product site. It aligns perfectly with the oncology sector, providing high-density clinical data, mandatory safety disclosures, and specific patient indications.
When links fail to express hierarchy, the model cannot form clusters or identify primary entities. Examine the Internal Linking Technical Guide and understand how structural signals—not navigation—define your semantic map.
“The score of 10 is driven primarily by the 'Identity and Authority' pillar (7/15) due to the absence of technical schema and the use of actor portrayals in place of named clinical authorities. All other pillars scored near zero due to the site's extreme reliance on verifiable clinical metrics and its complete avoidance of industry jargon or generic marketing templates.”